Kite Pharma competitors and similar companiesClear all

Kite Pharma's competitors and similar companies include G1 Therapeutics, Achilles Therapeutics, BioNTech, Amgen, Novartis, Juno Therapeutics and Adaptive Biotechnologies.
Kite Pharma
Kite Pharma
Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications.
G1 Therapeutics
G1 Therapeutics
G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.
Achilles Therapeutics
Achilles Therapeutics
Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.
BioNTech
BioNTech
BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
Juno Therapeutics
Juno Therapeutics
Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
Adaptive Biotechnologies
Adaptive Biotechnologies
Adaptive Biotechnologies is a biotechnology company that focuses on adaptive immune systems.
Founding Date
Founding Date
2009
Founding Date
2008
Founding Date
2016
Founding Date
2008
Founding Date
1980
Founding Date
1996
Founding Date
2013
Founding Date
2009
Type
Type
Subsidiary
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Santa Monica, US HQ
Amsterdam, NL
Hoofddorp, NL
Hayes, GB
Hayes, GB
El Segundo, US
Emeryville, US
see more
Locations
Durham, US HQ
Locations
London, GB HQ
Stevenage, GB
Locations
Mainz, DE HQ
Halle (Saale), DE
Idar Oberstein, DE
Marburg, DE
Neuried, DE
Planegg, DE
Cambridge, US
see more
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Sydney, AU
Wien, AT
Machelen, BE
Santo Amaro, BR
see more
Locations
Basel, CH HQ
Tirana, AL
Bir Mourad Raïs, DZ
Duc, AR
Macquarie Park, AU
Wien, AT
Baku, AZ
see more
Locations
Seattle, US HQ
Göttingen, DE
Göttingen, DE
München, DE
München, DE
Bothell, US
Brisbane, US
Locations
Seattle, US HQ
South San Francisco, US
Employees
Employees
3,4822% increase
Employees
12217% increase
Employees
153
Employees
1,94149% increase
Employees
24,200
Employees
104,3231% decrease
Employees
2331% decrease
Employees
85838% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
239.8 m
Valuation ($)
N/A
Valuation ($)
40.3 b
Valuation ($)
161.1 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
1.3 b
Twitter followers
Twitter followers
4.9 k
Twitter followers
1.3 k
Twitter followers
434
Twitter followers
80.3 k
Twitter followers
124.8 k
Twitter followers
302.4 k
Twitter followers
2.5 k
Twitter followers
4.7 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
11
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
7
Number of tweets (last 30 days)
94
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
11
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
7.7
Average likes per tweet (last 30 days)
1.6
Average likes per tweet (last 30 days)
4
Average likes per tweet (last 30 days)
130.9
Average likes per tweet (last 30 days)
6.9
Average likes per tweet (last 30 days)
4.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3.4
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
81.82%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
97.87%
Percentage of tweets with engagement (last 30 days)
50%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
90.91%
Alexa Website Rank
Alexa Website Rank
450305
Alexa Website Rank
411905
Alexa Website Rank
211045
Alexa Website Rank
416012
Alexa Website Rank
118547
Alexa Website Rank
129099
Alexa Website Rank
N/A
Alexa Website Rank
326279
Employee Rating
Employee Rating
3.8
Employee Rating
3.4
Employee Rating
3.7
Employee Rating
3.3
Employee Rating
4.1
Employee Rating
4.2
Employee Rating
3.9
Employee Rating
3.6

Financial

Revenue (est.)
Revenue (est.)
$22.2m (FY, 2016)
Revenue (est.)
$31.5m (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
€19b (FY, 2021)
Revenue (est.)
$26b (FY, 2021)
Revenue (est.)
$52.9b (FY, 2021)
Revenue (est.)
$111.9m (FY, 2017)
Revenue (est.)
$154.3m (FY, 2021)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
€2.9b (FY, 2021)
Cost of goods
$6.5b (FY, 2021)
Cost of goods
$9.7b (FY, 2021)
Cost of goods
N/A
Cost of goods
$49.3m (FY, 2021)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
€16.2b (FY, 2021)
Gross profit
$19.5b (FY, 2021)
Gross profit
$45.1b (FY, 2021)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($267.1m) (FY, 2016)
Net income
($148.4m) (FY, 2021)
Net income
($61.1m) (FY, 2021)
Net income
€10.3b (FY, 2021)
Net income
$5.9b (FY, 2021)
Net income
$24b (FY, 2021)
Net income
($437.1m) (FY, 2017)
Net income
($207.3m) (FY, 2021)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
40 (FY, 2020)
Patents (US)
N/A
Patents (US)
45 (Oct, 2019)
Patents (US)
31 (FY, 2020)
Patents (US)
N/A
Patents (US)
72 (FY, 2016)
Patents (US)
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
8 (Oct, 2019)
Phase I Trials Products
20 (FY, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
1 (Oct, 2019)
Phase II Trials Products
5 (FY, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
11 (FY, 2020)
Phase III Trials Products
54 (FY, 2021)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Trademarks (US)
Trademarks (US)
N/A
Trademarks (US)
N/A
Trademarks (US)
3 (May, 2021)
Trademarks (US)
8 (Oct, 2019)
Trademarks (US)
N/A
Trademarks (US)
N/A
Trademarks (US)
N/A
Trademarks (US)
N/A

Funding

Total funding raised
Total funding raised
$ 85.3m
Total funding raised
$ 289.6m
Total funding raised
$ 138.1m
Total funding raised
$ 1.4b
Total funding raised
N/A
Total funding raised
$ 6.5m
Total funding raised
$ 310m
Total funding raised
$ 524.9m
For sources of this data, please see the company profile

View company profiles

G1 Therapeutics
HQ
Durham, US
Employees
122↑ 17% increase

G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.

View company
Achilles Therapeutics
HQ
London, GB
Employees
153

Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.

View company
BioNTech
HQ
Mainz, DE
Employees
1,941↑ 49% increase

BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.

View company
Amgen
HQ
Thousand Oaks, US
Employees
24,200

Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.

View company